SKLB-03220
SKLB-03220 is a selective and orally active EZH2 covalent inhibitor with an IC50 of 1.72 nM for EZH2MUT. SKLB-03220 exhibits weak activities against other tested histone methyltransferases (HMTs) and kinases. SKLB-03220 displays noteworthy potency against ovarian cancer cell lines and induces cell apoptosis. SKLB-03220 significantly inhibits tumor growth in PA-1 xenograft model. SKLB-03220 can be used for the study of ovarian cancer.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 2852050-29-2
- Formel: C33H40N4O4
- Molecular Weight:556.70
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle Histone Methyltransferase Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
|
EZH2 WT 1.72 nM (IC50) |
EZH2 Y641N |
EZH2 Y641F mutant type |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| 4T1 | IC50 |
24.5 μM
Compound: 12d; SKLB-03220
|
Antiproliferative activity against mouse 4T1 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antiproliferative activity against mouse 4T1 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 36692394] |
| A2780 | IC50 |
11.2 μM
Compound: 12d; SKLB-03220
|
Antiproliferative activity against human A2780 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antiproliferative activity against human A2780 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 36692394] |
| A549 | IC50 |
28.7 μM
Compound: 12d; SKLB-03220
|
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 36692394] |
| BT-549 | IC50 |
18.9 μM
Compound: 12d; SKLB-03220
|
Antiproliferative activity against human BT-549 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antiproliferative activity against human BT-549 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 36692394] |
| ES-2 | IC50 |
36.4 μM
Compound: 12d; SKLB-03220
|
Antiproliferative activity against human ES2 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antiproliferative activity against human ES2 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 36692394] |
| HEY | IC50 |
35.5 μM
Compound: 12d; SKLB-03220
|
Antiproliferative activity against human HEY cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antiproliferative activity against human HEY cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 36692394] |
| MCF7 | IC50 |
56.2 μM
Compound: 12d; SKLB-03220
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 36692394] |
| NCI-H1703 | IC50 |
26.3 μM
Compound: 12d; SKLB-03220
|
Antiproliferative activity against human NCI-H1703 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antiproliferative activity against human NCI-H1703 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 36692394] |
| OAW-42 | IC50 |
>100 μM
Compound: 12d; SKLB-03220
|
Antiproliferative activity against human OAW-42 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antiproliferative activity against human OAW-42 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 36692394] |
| OVCAR-3 | IC50 |
35.6 μM
Compound: 12d; SKLB-03220
|
Antiproliferative activity against human OVCAR-3 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antiproliferative activity against human OVCAR-3 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 36692394] |
| PA-1 | IC50 |
10.1 μM
Compound: 12d; SKLB-03220
|
Antiproliferative activity against human PA-1 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antiproliferative activity against human PA-1 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 36692394] |
| SK-BR-3 | IC50 |
22.8 μM
Compound: 12d; SKLB-03220
|
Antiproliferative activity against human SK-BR-3 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antiproliferative activity against human SK-BR-3 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 36692394] |
| SK-OV-3 | IC50 |
56.4 μM
Compound: 12d; SKLB-03220
|
Antiproliferative activity against human SK-OV-3 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antiproliferative activity against human SK-OV-3 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 36692394] |
SKLB-03220 (0.5-10 μM, 3-14 days) inhibits PA-1 and A2780 cell proliferation and colony formation[1].
SKLB-03220 (5-40 μM, 48 h) induces apoptosis of PA-1 cells[1].
SKLB-03220 (0-5 μM, 0-4 d) inhibits the expression of H3K27me3 in PA-1 cells[1].
SKLB-03220 (10 μM, 3 d + washout 0-4 d) achieves persistent target inhibition and long-lasting anti-tumor effects in PA-1 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:PA-1 cells
-
Concentration:5, 10, 20 and 40 μM
-
Incubation Time:48 h
-
Result:Induced ovarian cancer cell apoptosis in a dose-dependent manner.
-
Cell Line:PA-1 cells
-
Concentration:0, 0.3, 0.6, 1.2, 2.5 and 5 μM
-
Incubation Time:0, 1, 2, 3, 4 d
-
Result:Effectively and persistently reduced the level of H3K27me3 within the cells, without affecting the total protein quantity of EZH2.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:PA-1 cells xenograft model established in BALB/C nude mice (6 weeks)[1]
-
Dosage:75 and 150 mg/kg
-
Administration:Oral administration (p.o.), twice daily for 21 days
-
Result:Significantly inhibits tumor growth in a dose-dependent manner. Reduced the Ki-67 and H3K27me3 signals and increased cleaved Caspase-3 in tumor tissues. No significant abnormalities were observed in terms of body weight, blood routine, blood biochemical indicators, and pathological sections of major organs.
Chemical Information
-
CAS. Nr. 2852050-29-2
-
Molecular Weight 556.70
-
Formel C33H40N4O4
-
SMILES
O=C(NC1=CC=C(C)C(C2=CC(N(C3CCOCC3)CC)=C(C)C(C(NCC4=C(C)C=C(C)NC4=O)=O)=C2)=C1)C=C
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)